WallStSmart

Alphatec Holdings Inc (ATEC)vsBoston Scientific Corp (BSX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Boston Scientific Corp generates 2476% more annual revenue ($21.00B vs $815.05M). BSX leads profitability with a 17.5% profit margin vs -13.5%. ATEC appears more attractively valued with a PEG of 0.48. BSX earns a higher WallStSmart Score of 72/100 (B).

ATEC

Hold

42

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 8.3Quality: 6.0
Piotroski: 5/9Altman Z: -1.68

BSX

Strong Buy

72

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 6.7Quality: 5.5
Piotroski: 5/9Altman Z: 1.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ATECUndervalued (+35.1%)

Margin of Safety

+35.1%

Fair Value

$20.77

Current Price

$10.58

$10.19 discount

UndervaluedFair: $20.77Overvalued
BSXOvervalued (-10.0%)

Margin of Safety

-10.0%

Fair Value

$39.07

Current Price

$42.98

$3.91 premium

UndervaluedFair: $39.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ATEC3 strengths · Avg: 9.3/10
PEG RatioValuation
0.4810/10

Growing faster than its price suggests

Debt/EquityHealth
-50.0510/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
15.1%8/10

15.1% revenue growth

BSX6 strengths · Avg: 8.2/10
Market CapQuality
$62.29B9/10

Large-cap with strong market position

PEG RatioValuation
0.608/10

Growing faster than its price suggests

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Free Cash FlowQuality
$1.28B8/10

Generating 1.3B in free cash flow

Areas to Watch

ATEC4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.39B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-686.7%2/10

ROE of -686.7% — below average capital efficiency

Altman Z-ScoreHealth
-1.682/10

Distress zone — elevated risk

BSX1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.784/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ATEC

The strongest argument for ATEC centers on PEG Ratio, Debt/Equity, Revenue Growth. Revenue growth of 15.1% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.

Bull Case : BSX

The strongest argument for BSX centers on Market Cap, PEG Ratio, P/E Ratio. Profitability is solid with margins at 17.5% and operating margin at 22.9%. PEG of 0.60 suggests the stock is reasonably priced for its growth.

Bear Case : ATEC

The primary concerns for ATEC are EPS Growth, Market Cap, Return on Equity.

Bear Case : BSX

The primary concerns for BSX are Altman Z-Score.

Key Dynamics to Monitor

ATEC profiles as a growth stock while BSX is a mature play — different risk/reward profiles.

ATEC carries more volatility with a beta of 0.85 — expect wider price swings.

ATEC is growing revenue faster at 15.1% — sustainability is the question.

BSX generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

BSX scores higher overall (72/100 vs 42/100), backed by strong 17.5% margins. ATEC offers better value entry with a 35.1% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alphatec Holdings Inc

HEALTHCARE · MEDICAL DEVICES · USA

Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Want to dig deeper into these stocks?